DBV Technologies S.A.

€1.79As of Sun 8 Nov 2026, 12:00 UTC
EPA:DBVHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR (29.88%)
Div yield —
ROE (205.85%)
Biotechnology
Beta (5Y) (0.21)
PE TTM —
TSR TTM (31.62%)
Mkt cap €564.0M
ROIC (120.22%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€2.25
25.11%
392.73%
Hold 9|7|6|5|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.04
0.04
0.04
4.66%
4.15%
10.07%
13.05%
Revenue$M
38.70
39.48
38.31
37.49
7.19%
4.54%
3.18%
(3.16%)
Peers (US$633.3M)
Cap (US$)
PE
902.0M
—
595.5M
—
534.5M
—
Capital
TTM
5Y
10Y
Leveragex
0.655
0.253
0.240
EBIT/Intx
3.284
0.089
0.089
Own earn%
68.56
214.38
160.52
Sh yield%
19.33
50.30
50.24
Owners
Insiders/Inst%
13.58
59.70
Short interest%
3.23
SBC / revenue%
5.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
7–11
$1 testx
0.5
Incr. ROIC%
5